Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.39 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 3/20 | 0.36 |
| ▸ | CES1 | P23141 | 3/20 | 0.36 |
| ▸ | TRPM8 | Q7Z2W7 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3976195 | 1.00 | LMNA (0.45) | LMNALPAR3LPAR1LPAR2DGKA | |
| SCHEMBL333601 | 0.83 | — | — | |
| Decane SCHEMBL3985767 | 0.81 | LMNA (0.43) | LMNADGKAMAPTTSHRTHRB | |
| SCHEMBL3985770 | 0.81 | LMNA (0.43) | LMNADGKAMAPTTSHRTHRB | |
| SCHEMBL7950970 | 0.81 | FAAH (0.45) | LPAR3LPAR1LPAR2FAAH | |
| SCHEMBL7951580 | 0.81 | FAAH (0.45) | LPAR3LPAR1LPAR2FAAH | |
| SCHEMBL7955618 | 0.81 | FAAH (0.45) | LPAR3LPAR1LPAR2FAAH | |
| SCHEMBL27793045 | 0.81 | FAAH (0.45) | LPAR3LPAR1LPAR2FAAH | |
| SCHEMBL7953603 | 0.81 | FAAH (0.45) | LPAR3LPAR1LPAR2FAAH | |
| SCHEMBL2712776 | 0.81 | FAAH (0.45) | LPAR3LPAR1LPAR2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1840194-B1 | Gear fluids | AFTON CHEMICAL CORP (US) | 2009-05-13 | — | — | EP | disclosed |
| US-7410935-B2 | Gear fluids | AFTON CHEMICAL CORPORATION (US) | 2008-08-12 | — | — | US | disclosed |
| EP-1840194-A1 | Gear fluids | Afton Chemical Corporation (US) | 2007-10-03 | — | — | EP | disclosed |
| US-20070225182-A1 | Gear fluids | AFTON CHEMICAL CORPORATION | 2007-09-27 | — | — | US | disclosed |
| EP-1785475-A1 | A gear additive composition | Afton Chemical Corporation (US) | 2007-05-16 | — | — | EP | disclosed |
| US-20070105729-A1 | Gear additive composition | AFTON CHEMICAL CORPORATION | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225182-A1 | Gear fluids | PHOSPHO1, F12, PIK3CA | LMNA 4609/4885LPAR3 63/4885LPAR1 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.